Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06655493
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-21
Brief Title:
Levels of Inflammation in Middle East People With Cardiovascular Disease WithWithout Kidney Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Cross-sectional Study to Investigate Prevalence of Systemic Inflammation hsCRP in Cohort of Patients With HF and a Cohort of Patients With ASCVD and CKD in the Middle East
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
INFLAMEAST
Brief Summary:
This study will collect medical and background information from participants with diseases that affect the heart and blood vessels cardiovascular disease withwithout kidney disease
The aim of the study is to assess the number of people with high levels of systemic inflammation among Middle East people with cardiovascular withwithout kidney disease Systemic inflammation means that it occurs throughout the body
Participation in this study only requires a single visit at the clinichospitalmedical institution Participants will continue their normal care and will not get any treatment as part of this study
The aim of the study is to assess the number of people with high levels of systemic inflammation among Middle East people with cardiovascular withwithout kidney disease Systemic inflammation means that it occurs throughout the body
Participation in this study only requires a single visit at the clinichospitalmedical institution Participants will continue their normal care and will not get any treatment as part of this study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None